Novo Nordisk's Ozempic successor disappointed Wall Street again
Novo Nordisk (NVO) released clinical trial results for its potential Ozempic successor on Monday, disappointing Wall Street for the second time.Read more...
Novo Nordisk hands shelved Parkinson’s cell therapy to Zuckerberg-backed
<img src="https://media.thenextweb.com/2026/05/Novo-Nordisk.avif" width="868" height="488"><br /><p>Novo will take an equity stake in Cellular Intellige [...]
Novo Nordisk’s owner backs an Italian fund to grow drug startups beyond D
<img src="https://media.thenextweb.com/2026/05/Novo-Nordisk.avif" width="868" height="488"><br /><p>Novo Holdings, the investment company that controls [...]
Wegovy's price cut, Amgen's Ozempic competitor, and Big Pharma
<img class="type:primaryImage" src="https://i.kinja-img.com/image/upload/c_fit,q_80,w_636/e52d965976c1e0c2f8d89ccb548a2577.jpg"/><p>Novo Nordisk just cut the price of i [...]